GEN Exclusives

More »

Jun. 1, Vol. 26, No. 11

    • Point of View

      • Marijuana, Medicine & the FDA
      • On April 20, the FDA jumped into the medical marijuana controversy with a statement that was puzzling on many levels and should leave all Americans concerned about the politicization of the agency we depend on to protect our health. The document pro ... more »
    • Legal Affairs

      • When is Private Really Public?
      • Good news for inventors. Using an invention secretly in one&#8217s own shop, even for a period longer than a year, will not by itself cause a court to invalidate a patent filed later to protect the invention. This rule was pronounced in response ... more »
    • Wall Street BioBeat

      • Reverse Mergers in Life Science Financing
      • Life science companies that have plunged into the IPO waters over the past few years have likely found the temperature, at best, tepid. Rather than being warmly embraced by the public markets, as was the case in the not too distant past, the recepti ... more »
    • Feature Articles

      • Biofirms Develop Novel Therapeutics for MS
      • Acorda Therapeutics (www.acorda.com) recently completed enrollment of its Phase III trial of Fampridine-SR in multiple sclerosis (MS). The study, which is based on a Special Protocol Assessment issued by the FDA, is evaluating the safety and efficac ... more »
      • Chromatography Advances Drug Discovery
      • Companies are addressing requests for higher throughput with higher resolution in chromatography by developing more sophisticated platforms. In addition, many are introducing nanoscale instruments for protein separation and addressing niche markets ... more »
      • GEN's Annual Top 20 Molecular Millionaires
      • Genetic Engineering News is pleased to present the 2006 version of GEN&#8217s Molecular Millionaires. This is our annual listing of doctoral-degree-holding individuals who have made millions through ownership of biotechnology and pharmaceutical ... more »
      • SNP Genotyping Methods Surge Ahead
      • The genetic makeup of a human being is determined by DNA sequences that are made up of four nucleotides, adenine, cytosine, thymine, and guanine, in a multitude of combinations. Variations in these DNA sequences can alter the genetic code and result ... more »
      • Target Screening Focuses on Ion Channels
      • Elizabeth Lipp
      • More is not necessarily better, as was previously examined in an article about the pitfalls of high-throughput screening (GEN, March 15, 2006, pg. 24), not the least of which is the terabytes of information it creates and the time it takes to cull t ... more »
      • Trends & Expectations in Bioinformatics
      • It is now hard to imagine a biological laboratory without bioinformatics tools. In the last 10 years, bioinformatics has surpassed its original definition of software technologies aiding in annotation and manipulation of genetic information. Today&a ... more »
    • Tutorials

      • Assay Tutorial: Adenoviral Vector Gene Delivery System
      • Biological assays in established and primary cells can greatly aid the drug discovery process. Stable cell (inheritable genotype) lines are chosen for their consistent profile and efficient measure of compound activity. Transient cell-based assays o ... more »
      • Microbial and Cell Growth in Microtiter Plates
      • Construct and mutant libraries, as well as collections of bacteria, fungi, and streptomycetes and eukaryotic cell lines are being used in a wide range of research areas. As diverse as these areas may beranging from traditional streptomycete screenin ... more »
      • Protein Tomography Applications Expand
      • Confidently predicting clinical outcome from research in the discovery phase of drug development remains a major dilemma for pharmaceutical companies. The problem is particularly acute in the transfer of studies of human disease from human biology i ... more »
    • Corporate Profiles

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?